Showing 7661-7670 of 10623 results for "".
- Study Highlights Widespread Childhood Adversity: 80.5 Percent of Adolescents Affectedhttps://reachmd.com/news/study-highlights-widespread-childhood-adversity-805-percent-of-adolescents-affected/2468746/Adverse childhood experiences (ACEs) are highly prevalent among U.S. adolescents, with 80.5 percent reporting at least one ACE, according to a new study published in Pediatrics. This study provides critical insights into the types and frequency of ACEs and underscores disparities across
- Report: Global Atopic Dermatitis Market Poised for Rapid Expansionhttps://reachmd.com/news/report-global-atopic-dermatitis-market-poised-rapid-expansion/2468755/The atopic dermatitis (AD) market is forecasted to grow from $5.3 billion in 2021 to $22.6 billion by 2031, with a compound annual growth rate (CAGR) of 15.1%, according to a new report. North America as the current market leader, according to a press release from Allied Market Research,
- Sleep Disorder and Chronic Kidney Disease May Have Bidirectional Association, Unravels Studyhttps://reachmd.com/news/sleep-disorder-and-chronic-kidney-disease-may-have-bidirectional-association-unravels-study/2468717/A new meta-analysis published in the recent issue of Clinical Kidney Journal revealed a significant bidirectional relationship between chronic kidney disease (CKD) and various sleep disorders, including obstructive sleep apnea (OSA), restless leg syndrome (RLS), and insomnia. The
- UTHealth Study Could Set New Standards for Treating Acromioclavicular Joint Injuries in Athleteshttps://reachmd.com/news/uthealth-study-could-set-new-standards-for-treating-acromioclavicular-joint-injuries-in-athletes/2468722/A new UTHealth Houston study focused on finding the best surgical technique for reconstruction of the acromioclavicular joint (ACJ), where the collarbone meets the shoulder blade, has the potential to enhance recovery and long-term shoulder health
- New Oral Peptide Therapy Targets Chronic Abdominal Pain Without Opioid Riskshttps://reachmd.com/news/new-oral-peptide-therapy-targets-chronic-abdominal-pain-without-opioid-risks/2468684/Chronic abdominal pain, a debilitating symptom of conditions like irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD), has long relied on opioids for relief—despite their severe side effects and addiction risks. A team at the University of Vienna, led by medicinal chemist Markus
- Symptom Screening Reduces Symptom Burden in Pediatric Cancer Patients, Study Findshttps://reachmd.com/news/symptom-screening-reduces-symptom-burden-in-pediatric-cancer-patients-study-finds/2468675/Pediatric cancer treatments are known to cause significant physical and emotional discomfort, and addressing these symptoms is an important part of care. A new study led by researchers from the University of Toronto and The Hospital for Sick Children (SickKids), published in JAMA, demons
- Racial Disparities Persist in Carotid Endarterectomy Outcomes, Study Findshttps://reachmd.com/news/racial-disparities-persist-in-carotid-endarterectomy-outcomes-study-finds/2468667/A new study reveals that non-white patients are twice as likely as white patients to die within 30 days of carotid endarterectomy, a common surgical procedure to reduce stroke risk. Despite advancements in medical practice, these racial disparities in outcomes have persisted for decades, highligh
- New Method Maps Gene Activity in the Living Human Brainhttps://reachmd.com/news/new-method-maps-gene-activity-in-the-living-human-brain/2468687/In a groundbreaking study, researchers at FutureNeuro, the RCSI University of Medicine and Health Sciences, and international collaborators have developed a novel approach to profile gene activity in the living human brain. Published in JCI Insight, this innovative technique overcomes lo
- Atopic Dermatitis Insights from SDPA: Innovations and Barriers in Carehttps://reachmd.com/news/atopic-dermatitis-insights-from-sdpa-innovations-and-barriers-in-care/2468680/At the SDPA’s 22nd Annual Fall Dermatology Conference, Matthew Zirwas, MD, delivered an engaging lecture titled “Managing Atopic Dermatitis: Innovations, Challenges, and Care Strategies.” Dr. Zirwas shared critical insights into the evolving understanding of atopic dermatitis (AD), with a focus o
- Inebilizumab Significantly Reduces Disease Flares in Patients With IgG4-Related Diseasehttps://reachmd.com/news/inebilizumab-significantly-reduces-disease-flares-in-patients-with-igg4-related-disease/2468691/A groundbreaking phase 3 clinical trial led by Mass General Brigham has identified inebilizumab as a promising treatment for immunoglobulin G4-related disease (IgG4-RD), a rare but debilitating condition. Published in the New England Journal of Medicine, the study revealed that inebilizu